Simvastatin attenuates TNF‑α‑induced apoptosis in endothelial progenitor cells via the upregulation of SIRT1

  • Authors:
    • Gang Du
    • Yunlin Song
    • Tao Zhang
    • Long Ma
    • Ning Bian
    • Xiaoming Chen
    • Jianyi Feng
    • Qing Chang
    • Zicheng Li
  • View Affiliations

  • Published online on: April 9, 2014     https://doi.org/10.3892/ijmm.2014.1740
  • Pages: 177-182
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Endothelial progenitor cells (EPCs) originate from the bone marrow and can be classified as either early or late EPCs. The focus of this study was on late EPCs, as they play an important role in angiogenesis and vascular proliferation. Evidence suggests that inflammatory and oxidative changes can increase EPC apoptosis. Of note, tumor necrosis factor-α (TNF-α) is a contributing risk factor to the development of atherosclerosis and plays a key role as both an inflammatory mediator and an inducer of apoptosis in endothelial cells. Additionally, a member of the sirtuin family, silent information regulator type-1 (SIRT1), promotes cell survival by repressing p53- and non-p53-dependent apoptosis in response to DNA damage and oxidative stress. Statins have also been shown to play a key role in the prevention of endothelial apoptosis and senescence via their lipid-lowering and anti-inflammatory actions. However, there is little evidence that statins themselves attenuate EPC apoptosis induced by TNF-α. The aim of this study was to demonstrate the effectiveness of one of the most commonly used statins, simvastatin, on decreasing TNF-α-induced apoptosis in EPCs. The results indicated that SIRT1 protein expression was decreased by TNF-α in a time- and dose-dependent manner and that while TNF-α caused a marked increase in the percentage of apoptotic EPCs, application of simvastatin decreased this percentage. A high concentration of simvastatin promoted the expression of SIRT1 and increased the proliferation of EPCs. In conclusion, findings of this study showed that simvastatin is crucial in counteracting the TNF-α-induced apoptosis of EPCs and that this protection may involve the actions of SIRT1.
View Figures
View References

Related Articles

Journal Cover

July 2014
Volume 34 Issue 1

Print ISSN: 1107-3756
Online ISSN:1791-244X

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
APA
Du, G., Song, Y., Zhang, T., Ma, L., Bian, N., Chen, X. ... Li, Z. (2014). Simvastatin attenuates TNF‑α‑induced apoptosis in endothelial progenitor cells via the upregulation of SIRT1. International Journal of Molecular Medicine, 34, 177-182. https://doi.org/10.3892/ijmm.2014.1740
MLA
Du, G., Song, Y., Zhang, T., Ma, L., Bian, N., Chen, X., Feng, J., Chang, Q., Li, Z."Simvastatin attenuates TNF‑α‑induced apoptosis in endothelial progenitor cells via the upregulation of SIRT1". International Journal of Molecular Medicine 34.1 (2014): 177-182.
Chicago
Du, G., Song, Y., Zhang, T., Ma, L., Bian, N., Chen, X., Feng, J., Chang, Q., Li, Z."Simvastatin attenuates TNF‑α‑induced apoptosis in endothelial progenitor cells via the upregulation of SIRT1". International Journal of Molecular Medicine 34, no. 1 (2014): 177-182. https://doi.org/10.3892/ijmm.2014.1740